Literature DB >> 6633661

Direct enzyme transfer from lymphocytes is specific.

I Olsen, H Muir, R Smith, A Fensom, D J Watt.   

Abstract

Lymphocytes are known to interact directly with other cells in vivo and in vitro, and have recently been shown to transfer the lysosomal enzyme, beta-glucuronidase, to fibroblasts from patients with an inherited deficiency of the enzyme. This process requires cell-cell contact, is unaffected by inhibitors of 'classical' receptor-mediated endocytosis and is abolished by inhibitors of protein synthesis. Although it is not yet known to what extent the transfer of enzymes by direct cellular interaction is a general phenomenon, a similar mechanism could possibly be involved in the transfer of other lysosomal enzymes in vivo and in the exchange of protein in vitro. We show here that the direct transfer of enzymes from lymphocytes to fibroblasts is restricted to only certain lysosomal enzymes.

Entities:  

Mesh:

Year:  1983        PMID: 6633661     DOI: 10.1038/306075a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  9 in total

1.  Direct transfer in vitro of alpha-D-mannosidase activity from normal lymphocytes to fibroblasts of a patient with alpha-mannosidosis.

Authors:  M Margollicci; G Bartalini; P Balestri; A Fois
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Ultrastructural localization of a lysosomal enzyme in resin-embedded lymphocytes.

Authors:  G Bou-Gharios; J Moss; I Olsen; T Partridge
Journal:  Histochemistry       Date:  1988

Review 3.  Lysosomal storage diseases: mechanisms of enzyme replacement therapy.

Authors:  G Bou-Gharios; D Abraham; I Olsen
Journal:  Histochem J       Date:  1993-09

4.  Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice.

Authors:  Yoichi Kondo; David A Wenger; Vittorio Gallo; Ian D Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

5.  Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.

Authors:  M S Sands; C Vogler; A Torrey; B Levy; B Gwynn; J Grubb; W S Sly; E H Birkenmeier
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

6.  Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system.

Authors:  R M Shull; N E Hastings; R R Selcer; J B Jones; J R Smith; W C Cullen; G Constantopoulos
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

7.  Stereological and morphometric analysis of dermal fibroblasts before and after bone marrow transplantation in a case of mucopolysaccharidosis I Scheie phenotype.

Authors:  M Costa; J García Valero; C Navarro
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Long-term effects of bone marrow transplantation on lysosomal enzyme replacement in beta-glucuronidase-deficient mice.

Authors:  G Bou-Gharios; G Adams; P Pace; I Olsen
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

9.  Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges.

Authors:  Sevil Köse; Fatima Aerts-Kaya; Duygu Uçkan Çetinkaya; Petek Korkusuz
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.